首页> 外文期刊>International Journal of Research in Medical Sciences >Antimicrobial resistance in bacteria causing ventilator-associated pneumonia in a tertiary care hospital: one year prospective study
【24h】

Antimicrobial resistance in bacteria causing ventilator-associated pneumonia in a tertiary care hospital: one year prospective study

机译:细菌中的抗菌药物抗性导致呼吸机相关的肺炎在第三级护理医院:一年前瞻性研究

获取原文
           

摘要

Background: Ventilator-associated pneumonia (VAP) is the most common infection diagnosed in intensive care units (ICUs). The causative organisms of VAP vary among different populations and are increasingly associated with resistance against various antimicrobial agents. Objective of current study was to determine the bacteriological etiology of VAP, antimicrobial susceptibility pattern of the isolates and detect the presence of extended-spectrum β-lactamases (ESBL), metallo β-lactamases (MBL) and AmpC β-lactamases in multidrug resistant isolates causing VAP in the medical ICU. Methods: A prospective study was carried out over a year to know the various etiological agents of VAP and their drug susceptibility patterns. ESBL, MBL and AmpC β-lactamases were detected in various isolates by combination disk method, imipenem-EDTA combined disk method and AmpC disk method respectively. Results: The majority of bacterial isolates causing VAP were found to be gram negative bacilli. Acinetobacter spp accounted for 34.28% of VAP cases followed by Pseudomonas aeruginosa which was responsible for 25.71% cases. Other gram negative bacilli isolated were Klebsiella pneumoniae, Citrobacter freundii, Enterobacter spp, and Escherichia coli. Out of the total 70 isolates, 67 (95.7%) were multidrug resistant and not even a single isolate was sensitive to all the drugs tested. Conclusions: Most of the pathogens causing VAP in our institute were multidrug resistant and in many isolates this resistance was due to production of ESBL, MBL, and AmpC β-latamases. Polymixin-B and colistin were found to be highly effective against multidrug resistant Acinetobacter spp and P. aeruginosa.
机译:背景:呼吸机相关的肺炎(VAP)是在重症监护单位(ICU)中诊断出最常见的感染。 VAP的致病生物在不同的群体中变化,并且越来越多地与针对各种抗微生物剂的抗性相关。目的的目的是确定VAP的细菌病因,分离物的抗微生物易感模式,并检测多药隔离物中延长光谱β-内酰胺酶(ESBL),金属β-内酰胺(MBL)和AMPCβ-内酰胺酶的存在导致医疗ICU中的VAP。方法:一年多次进行前瞻性研究,以了解VAP的各种病因及其药物易感模式。通过组合盘法,IMIPENEM-EDTA组合磁盘法和AMPC磁盘方法在各种分离物中检测ESBL,MBL和AMPCβ-乳酰胺酶。结果:发现导致VAP的大部分细菌分离物是革兰氏菌。 Acinetobacter SPP占VAP病例的34.28%,然后是假单胞菌铜绿假单胞菌,其负责25.71%的病例。被隔绝的其他克阴性肉桂杆菌是克莱布拉肺炎,植物杆菌freundii,肠杆菌spp和大肠杆菌。除了总共70分离物中,67(95.7%)是多药抗性,甚至单一分离物也不敏感所有测试的药物。结论:在我们的研究所中导致VAP的大多数病原体是多药抗性,并且在许多隔离物中,这种阻力是由于ESBL,MBL和AMPCβ-拉米酶的产生。发现明屈剂蛋白-B和Colistin对多药抗性抗易用杆菌和P.铜绿假单胞菌具有高效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号